REPORT ID 6502

United States Erectile Dysfunction(ED) Drug Market Report 2017

Publish Date
26-Dec-17
Pages
97
Format
Electronic (PDF)

In this report, the United States Erectile Dysfunction(ED) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Erectile Dysfunction(ED) Drug in these regions, from 2012 to 2022 (forecast).

United States Erectile Dysfunction(ED) Drug market competition by top manufacturers/players, with Erectile Dysfunction(ED) Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Lilly
    Bayer
    Johnson & Johnson
    Baiyunshan Pharmaceutical Company
    Cipla
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Vardenafil
    Avanafil
    Tadalafil
    Vardenafil
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Supermarket
    Online Store
    Pharmacy
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Erectile Dysfunction(ED) Drug Market Report 2017
1 Erectile Dysfunction(ED) Drug Overview
    1.1 Product Overview and Scope of Erectile Dysfunction(ED) Drug
    1.2 Classification of Erectile Dysfunction(ED) Drug by Product Category
        1.2.1 United States Erectile Dysfunction(ED) Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Erectile Dysfunction(ED) Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Vardenafil
        1.2.4 Avanafil
        1.2.5 Tadalafil
        1.2.6 Vardenafil
    1.3 United States Erectile Dysfunction(ED) Drug Market by Application/End Users
        1.3.1 United States Erectile Dysfunction(ED) Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Supermarket
        1.3.3 Online Store
        1.3.4 Pharmacy
        1.3.5 Other
    1.4 United States Erectile Dysfunction(ED) Drug Market by Region
        1.4.1 United States Erectile Dysfunction(ED) Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
        1.4.3 Southwest Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
        1.4.5 New England Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
        1.4.6 The South Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
        1.4.7 The Midwest Erectile Dysfunction(ED) Drug Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Erectile Dysfunction(ED) Drug (2012-2022)
        1.5.1 United States Erectile Dysfunction(ED) Drug Sales and Growth Rate (2012-2022)
        1.5.2 United States Erectile Dysfunction(ED) Drug Revenue and Growth Rate (2012-2022)

2 United States Erectile Dysfunction(ED) Drug Market Competition by Players/Suppliers
    2.1 United States Erectile Dysfunction(ED) Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Erectile Dysfunction(ED) Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Erectile Dysfunction(ED) Drug Average Price by Players/Suppliers (2012-2017)
    2.4 United States Erectile Dysfunction(ED) Drug Market Competitive Situation and Trends
        2.4.1 United States Erectile Dysfunction(ED) Drug Market Concentration Rate
        2.4.2 United States Erectile Dysfunction(ED) Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Erectile Dysfunction(ED) Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Erectile Dysfunction(ED) Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Erectile Dysfunction(ED) Drug Sales and Market Share by Region (2012-2017)
    3.2 United States Erectile Dysfunction(ED) Drug Revenue and Market Share by Region (2012-2017)
    3.3 United States Erectile Dysfunction(ED) Drug Price by Region (2012-2017)

4 United States Erectile Dysfunction(ED) Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Erectile Dysfunction(ED) Drug Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Erectile Dysfunction(ED) Drug Revenue and Market Share by Type (2012-2017)
    4.3 United States Erectile Dysfunction(ED) Drug Price by Type (2012-2017)
    4.4 United States Erectile Dysfunction(ED) Drug Sales Growth Rate by Type (2012-2017)

5 United States Erectile Dysfunction(ED) Drug Sales (Volume) by Application (2012-2017)
    5.1 United States Erectile Dysfunction(ED) Drug Sales and Market Share by Application (2012-2017)
    5.2 United States Erectile Dysfunction(ED) Drug Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Erectile Dysfunction(ED) Drug Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Lilly
        6.2.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Lilly Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Johnson & Johnson
        6.4.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Johnson & Johnson Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Baiyunshan Pharmaceutical Company
        6.5.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Cipla
        6.6.2 Erectile Dysfunction(ED) Drug Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Cipla Erectile Dysfunction(ED) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Erectile Dysfunction(ED) Drug Manufacturing Cost Analysis
    7.1 Erectile Dysfunction(ED) Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Erectile Dysfunction(ED) Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Erectile Dysfunction(ED) Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Erectile Dysfunction(ED) Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Erectile Dysfunction(ED) Drug Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Erectile Dysfunction(ED) Drug Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Erectile Dysfunction(ED) Drug Sales Volume Forecast by Type (2017-2022)
    11.3 United States Erectile Dysfunction(ED) Drug Sales Volume Forecast by Application (2017-2022)
    11.4 United States Erectile Dysfunction(ED) Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer